ABSTRACT
The ventral tegmental area (VTA) has dopamine, GABA, and glutamate neurons, which have been implicated in reward and aversion. Here, we determined whether VTA-glutamate or -GABA neurons play a role in innate defensive behavior. By VTA cell-type-specific genetic ablation, we found that ablation of glutamate, but not GABA, neurons abolishes escape behavior in response to threatening stimuli. We found that escape behavior is also decreased by chemogenetic inhibition of VTA-glutamate neurons and detected increases in activity in VTA-glutamate neurons in response to the threatening stimuli. By ultrastructural and electrophysiological analysis, we established that VTA-glutamate neurons receive a major monosynaptic glutamatergic input from the lateral hypothalamic area (LHA) and found that photoinhibition of this input decreases escape responses to threatening stimuli. These findings indicate that VTA-glutamate neurons are activated by and required for innate defensive responses and that information on threatening stimuli to VTA-glutamate neurons is relayed by LHA-glutamate neurons.
Subject(s)
Aggression/physiology , Glutamic Acid/physiology , Neurons/physiology , Ventral Tegmental Area/cytology , Ventral Tegmental Area/physiology , Animals , Escape Reaction , Humans , Hypothalamic Area, Lateral/cytology , Hypothalamic Area, Lateral/physiology , Hypothalamus/cytology , Hypothalamus/physiology , Mice , Neurons/ultrastructure , Optogenetics , Photic Stimulation , Reflex, Monosynaptic/physiology , Ventral Tegmental Area/ultrastructure , gamma-Aminobutyric Acid/physiologyABSTRACT
The ventral tegmental area (VTA) projection to the nucleus accumbens shell (NAcSh) regulates NAcSh-mediated motivated behaviors in part by modulating the glutamatergic inputs. This modulation is likely to be mediated by multiple substances released from VTA axons, whose phenotypic diversity is illustrated here by ultrastructural examination. Furthermore, we show in mouse brain slices that a brief optogenetic stimulation of VTA-to-NAc projection induced a transient inhibition of excitatory postsynaptic currents (EPSCs) in NAcSh principal medium spiny neurons (MSNs). This inhibition was not accompanied by detectable alterations in presynaptic release properties of electrically-evoked EPSCs, suggesting a postsynaptic mechanism. The VTA projection to the NAcSh releases dopamine, GABA and glutamate, and induces the release of other neuronal substrates that are capable of regulating synaptic transmission. However, pharmacological inhibition of dopamine D1 or D2 receptors, GABAA or GABAB receptors, NMDA receptors, P2Y1 ATP receptors, metabotropic glutamate receptor 5, and TRP channels did not prevent this short-term inhibition. These results suggest that an unknown mechanism mediates this form of short-term plasticity induced by the VTA-to-NAc projection.
Subject(s)
Axons/metabolism , Glutamic Acid/metabolism , Nucleus Accumbens/physiology , Ventral Tegmental Area/physiology , Animals , Axons/drug effects , Axons/ultrastructure , Dopamine Antagonists/pharmacology , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , Female , GABA Antagonists/pharmacology , Male , Mice , Microscopy, Electron , Neural Pathways/cytology , Neural Pathways/drug effects , Neural Pathways/metabolism , Neural Pathways/ultrastructure , Optogenetics , Serotonin Antagonists/pharmacology , Synaptic Transmission/drug effects , Synaptic Transmission/physiology , Ventral Tegmental Area/cytology , Ventral Tegmental Area/ultrastructureABSTRACT
Afferent inputs to the ventral tegmental area (VTA) control reward-related behaviors through regulation of dopamine neuron activity. The nucleus accumbens (NAc) provides one of the most prominent projections to the VTA; however, recent studies have provided conflicting evidence regarding the function of these inhibitory inputs. Using optogenetics, cell-specific ablation, whole cell patch-clamp and immuno-electron microscopy, we found that NAc inputs synapsed directly onto dopamine neurons, preferentially activating GABAB receptors. GABAergic inputs from the NAc and local VTA GABA neurons were differentially modulated and activated separate receptor populations in dopamine neurons. Genetic deletion of GABAB receptors from dopamine neurons in adult mice did not affect general or morphine-induced locomotor activity, but markedly increased cocaine-induced locomotion. Collectively, our findings demonstrate notable selectivity in the inhibitory architecture of the VTA and suggest that long-range GABAergic inputs to dopamine neurons fundamentally regulate behavioral responses to cocaine.
Subject(s)
Cocaine/pharmacology , Neural Inhibition/physiology , Nucleus Accumbens/physiology , Receptors, GABA-B/physiology , Reward , Ventral Tegmental Area/physiology , Animals , Dopaminergic Neurons/physiology , Dopaminergic Neurons/ultrastructure , Female , Gene Knockdown Techniques , Locomotion/drug effects , Locomotion/physiology , Male , Mice , Morphine/pharmacology , Receptor, Adenosine A1/physiology , Receptors, GABA-A/physiology , Receptors, GABA-B/biosynthesis , Receptors, GABA-B/genetics , Synaptic Transmission/physiology , Ventral Tegmental Area/ultrastructureABSTRACT
In utero exposure of rats to nicotine (NIC) provides a useful animal model for studying the impact of smoking during pregnancy on human offspring. Certain sequelae of prenatal NIC exposure suggest an impact on the development of the midbrain dopamine (DA) system, which receives a robust cholinergic innervation from the mesopontine tegmentum. We therefore investigated whether prenatal NIC induced structural changes in cells and synapses within the midbrain that persisted into adulthood. Osmotic minipumps delivering either sodium bitartrate (vehicle; VEH) or NIC bitartrate at 2 mg/kg/day were implanted into nine timed-pregnant dams at E4. At birth, rat pups were culled to litters of six males each, and the litters were cross-fostered. Plasma levels of NIC and cotinine from killed pups provided evidence of NIC exposure in utero. Pups separated from dams at weaning showed a trend toward reduced locomotor activity at this time point but not when tested again in adulthood. Adult rats were killed for anatomical studies. Estimates of brain size and volume did not vary with NIC treatment. Midbrain sections stained for Nissl or by immunoperoxidase for tyrosine hydroxylase and analyzed using unbiased stereology revealed no changes in volume or cell number in the substantia nigra compacta or ventral tegmental area as a result of NIC exposure. Within the ventral tegmental area, electron microscopic physical disector analysis showed no significant differences in the number of axon terminals or the number of asymmetric (putative excitatory) or symmetric (putative inhibitory) synapses. Although too infrequent to estimate by unbiased stereology, no obvious difference in the proportion of cholinergic axons was noted in NIC- versus VEH-treated animals. These data suggest that activation of nicotinic receptors during prenatal development induces no significant modifications in the structure of cells in the ventral midbrain when assessed in adulthood.
Subject(s)
Dopaminergic Neurons/drug effects , Dopaminergic Neurons/ultrastructure , Mesencephalon/drug effects , Mesencephalon/ultrastructure , Nicotine/administration & dosage , Prenatal Exposure Delayed Effects/pathology , Animals , Axons/drug effects , Axons/pathology , Axons/ultrastructure , Brain/drug effects , Brain/pathology , Brain/ultrastructure , Cotinine/blood , Dopamine/metabolism , Dopaminergic Neurons/pathology , Female , Locomotion/drug effects , Male , Mesencephalon/pathology , Nicotine/blood , Pars Compacta/drug effects , Pars Compacta/pathology , Pars Compacta/ultrastructure , Pregnancy , Rats , Synapses/drug effects , Synapses/pathology , Synapses/ultrastructure , Tyrosine 3-Monooxygenase/metabolism , Ventral Tegmental Area/drug effects , Ventral Tegmental Area/pathology , Ventral Tegmental Area/ultrastructureABSTRACT
Prenylated Rab acceptor family, member 2 (PRAF2) is a four transmembrane domain protein of 19 kDa that is highly expressed in particular areas of mammalian brains. PRAF2 is mostly found in the endoplasmic reticulum (ER) of neurons where it plays the role of gatekeeper for the GB1 subunit of the GABAB receptor, preventing its progression in the biosynthetic pathway in the absence of hetero-dimerization with the GB2 subunit. However, PRAF2 can interact with several receptors and immunofluorescence studies indicate that PRAF2 distribution is larger than the ER, suggesting additional biological functions. Here, we conducted an immuno-cytochemical study of PRAF2 distribution in mouse central nervous system (CNS) at anatomical, cellular and ultra-structural levels. PRAF2 appears widely expressed in various regions of mature CNS, such as the olfactory bulbs, cerebral cortex, amygdala, hippocampus, ventral tegmental area and spinal cord. Consistent with its regulatory role of GABAB receptors, PRAF2 was particularly abundant in brain regions known to express GB1 subunits. However, other brain areas where GB1 is expressed, such as basal ganglia, thalamus and hypothalamus, contain little or no PRAF2. In these areas, GB1 subunits might reach the cell surface of neurons independently of GB2 to exert biological functions distinct from those of GABAB receptors, or be regulated by other gatekeepers. Electron microscopy studies confirmed the localization of PRAF2 in the ER, but identified previously unappreciated localizations, in mitochondria, primary cilia and sub-synaptic region. These data indicate additional modes of GABAB regulation in specific brain areas and new biological functions of PRAF2.
Subject(s)
Brain/metabolism , Spinal Cord/metabolism , Vesicular Transport Proteins/metabolism , Animals , Brain/cytology , HEK293 Cells , Humans , Mice , Mitochondria/metabolism , Mitochondria/ultrastructure , Neurons/metabolism , Neurons/ultrastructure , Synapses/metabolism , Synapses/ultrastructure , Ventral Tegmental Area/metabolism , Ventral Tegmental Area/ultrastructureABSTRACT
The molecular mechanisms underlying drug extinction remain largely unknown, although a role for medial prefrontal cortex (mPFC) glutamate neurons has been suggested. Considering that the mPFC sends glutamate efferents to the ventral tegmental area (VTA), we tested whether the VTA is involved in methamphetamine (METH) extinction via conditioned place preference (CPP). Among various METH-CPP stages, we found that the amount of phospho-GluR1/Ser845 increased in the VTA at behavioral extinction, but not the acquisition or withdrawal stage. Via surface biotinylation, we found that levels of membrane GluR1 were significantly increased during METH-CPP extinction, while no change was observed at the acquisition stage. Specifically, the number of dendritic spines in the VTA was increased at behavioral extinction, but not during acquisition. To validate the role of the mPFC in METH-CPP extinction, we lesioned the mPFC. Ibotenic acid lesioning of the mPFC did not affect METH-CPP acquisition, however, it abolished the extinction stage and reversed the enhanced phospho-GluR1/Ser845 levels as well as increases in VTA dendritic spines during METH-CPP extinction. Overall, this study demonstrates that the mPFC plays a critical role in METH-CPP extinction and identifies the VTA as an alternative target in mediating the extinction of drug conditioning.
Subject(s)
Extinction, Psychological/drug effects , Extinction, Psychological/physiology , Methamphetamine/pharmacology , Prefrontal Cortex/physiology , Ventral Tegmental Area/drug effects , Ventral Tegmental Area/physiology , Animals , Conditioning, Psychological/drug effects , Drug-Seeking Behavior/drug effects , Drug-Seeking Behavior/physiology , Male , Mice, Inbred C57BL , Neuronal Plasticity/drug effects , Phosphorylation , Receptors, AMPA/metabolism , Ventral Tegmental Area/ultrastructureABSTRACT
BACKGROUND: Hypocretins/orexins (Hcrt/Ox) are hypothalamic neuropeptides involved in sleep-wakefulness regulation. Deficiency in Hcrt/Ox neurotransmission results in the sleep disorder narcolepsy, which is characterized by an inability to maintain wakefulness. The Hcrt/Ox neurons are maximally active during wakefulness and project widely to the ventral tegmental area (VTA). A dopamine-containing nucleus projecting extensively to the cerebral cortex, the VTA enhances wakefulness. In the present study, we used retrograde tracing from the medial prefrontal cortex (mPFC) to examine whether Hcrt1/OxA neurons target VTA neurons that could sustain behavioral wakefulness through their projections to mPFC. RESULTS: The retrograde tracer Fluorogold (FG) was injected into mPFC and, after an optimal survival period, sections through the VTA were processed for dual immunolabeling of anti-FG and either anti-Hcrt1/OxA or anti-TH antisera. Most VTA neurons projecting to the mPFC were located in the parabrachial nucleus of the ipsilateral VTA and were non-dopaminergic. Only axonal profiles showed Hcrt1/OxA-immunoreactivity in VTA. Hcrt1/OxA reactivity was observed in axonal boutons and many unmyelinated axons. The Hcrt1/OxA immunoreactivity was found filling axons but it was also observed in parts of the cytoplasm and dense-core vesicles. Hcrt1/OxA-labeled boutons frequently apposed FG-immunolabeled dendrites. However, Hcrt1/OxA-labeled boutons rarely established synapses, which, when they were established, were mainly asymmetric (excitatory-type), with either FG-labeled or unlabeled dendrites. CONCLUSIONS: Our results provide ultrastructural evidence that Hcrt1/OxA neurons may exert a direct synaptic influence on mesocortical neurons that would facilitate arousal and wakefulness. The paucity of synapses, however, suggest that the activity of VTA neurons with cortical projections might also be modulated by Hcrt1/OxA non-synaptic actions. In addition, Hcrt1/OxA could modulate the postsynaptic excitatory responses of VTA neurons with cortical projections to a co-released excitatory transmitter from Hcrt1/OxA axons. Our observation of Hcrt1/OxA targeting of mesocortical neurons supports Hcrt1/OxA wakefulness enhancement in the VTA and could help explain the characteristic hypersomnia present in narcoleptic patients.
Subject(s)
Axons/ultrastructure , Intracellular Signaling Peptides and Proteins/metabolism , Neurons/ultrastructure , Neuropeptides/metabolism , Prefrontal Cortex/ultrastructure , Synapses/ultrastructure , Ventral Tegmental Area/ultrastructure , Animals , Axons/metabolism , Cell Count , Fluorescent Antibody Technique , Immunohistochemistry , Male , Microscopy, Confocal , Microscopy, Electron , Neural Pathways/metabolism , Neural Pathways/ultrastructure , Neuroanatomical Tract-Tracing Techniques , Neurons/metabolism , Orexins , Prefrontal Cortex/metabolism , Rats, Sprague-Dawley , Stilbamidines , Synapses/metabolism , Tyrosine 3-Monooxygenase , Ventral Tegmental Area/blood supply , Ventral Tegmental Area/metabolismABSTRACT
The mesolimbic reward pathway arising from dopaminergic (DA) neurons of the ventral tegmental area (VTA) has been strongly implicated in reward processing and drug abuse. In rodents, behaviors associated with this projection are profoundly influenced by an orexinergic input from the lateral hypothalamus to the VTA. Because the existence and significance of an analogous orexigenic regulatory mechanism acting in the human VTA have been elusive, here we addressed the possibility that orexinergic neurons provide direct input to DA neurons of the human VTA. Dual-label immunohistochemistry was used and orexinergic projections to the VTA and to DA neurons of the neighboring substantia nigra (SN) were analyzed comparatively in adult male humans and rats. Orexin B-immunoreactive (IR) axons apposed to tyrosine hydroxylase (TH)-IR DA and to non-DA neurons were scarce in the VTA and SN of both species. In the VTA, 15.0±2.8% of TH-IR perikarya in humans and 3.2±0.3% in rats received orexin B-IR afferent contacts. On average, 0.24±0.05 and 0.05±0.005 orexinergic appositions per TH-IR perikaryon were detected in humans and rats, respectively. The majority (86-88%) of randomly encountered orexinergic contacts targeted the dendritic compartment of DA neurons. Finally, DA neurons of the SN also received orexinergic innervation in both species. Based on the observation of five times heavier orexinergic input to TH-IR neurons of the human, compared with the rat, VTA, we propose that orexinergic mechanism acting in the VTA may play just as important roles in reward processing and drug abuse in humans, as already established well in rodents.
Subject(s)
Axons/ultrastructure , Dopaminergic Neurons/ultrastructure , Hypothalamus/ultrastructure , Intracellular Signaling Peptides and Proteins/genetics , Neuropeptides/genetics , Substantia Nigra/ultrastructure , Ventral Tegmental Area/ultrastructure , Adult , Animals , Axons/metabolism , Dopaminergic Neurons/metabolism , Gene Expression , Humans , Hypothalamus/metabolism , Immunohistochemistry , Intracellular Signaling Peptides and Proteins/metabolism , Male , Middle Aged , Neuropeptides/metabolism , Orexins , Rats , Rats, Wistar , Reward , Substance-Related Disorders/metabolism , Substance-Related Disorders/physiopathology , Substance-Related Disorders/psychology , Substantia Nigra/metabolism , Tyrosine 3-Monooxygenase/genetics , Tyrosine 3-Monooxygenase/metabolism , Ventral Tegmental Area/metabolismABSTRACT
Alpha7 nicotinic acetylcholine receptors (α7nAChRs) mediate nicotine-induced burst-firing of dopamine neurons in the ventral tegmental area (VTA), a limbic brain region critically involved in reward and in dopamine D2 receptor (D2R)-related cortical dysfunctions associated with psychosis. The known presence of α7nAChRs and Gi-coupled D2Rs in dopamine neurons of the VTA suggests that these receptors are targeted to at least some of the same neurons in this brain region. To test this hypothesis, we used electron microscopic immunolabeling of antisera against peptide sequences of α7nACh and D2 receptors in the mouse VTA. Dual D2R and α7nAChR labeling was seen in many of the same somata (co-localization over 97%) and dendrites (co-localization over 49%), where immunoreactivity for each of the receptors was localized to endomembranes as well as to non-synaptic or synaptic plasma membranes often near excitatory-type synapses. In comparison with somata and dendrites, many more small axons and axon terminals were separately labeled for each of the receptors. Thus, single-labeled axon terminals were predominant for both α7nAChR (57.9%) and D2R (89.0%). The majority of the immunolabeled axonal profiles contained D2R-immunoreactivity (81.6%) and formed either symmetric or asymmetric synapses consistent with involvement in the release of both inhibitory and excitatory transmitters. Of 160 D2R-labeled terminals, 81.2% were presynaptic to dendrites that expressed α7nAChR alone or together with the D2R. Numerous glial processes inclusive of those enveloping either excitatory- or inhibitory-type synapses also contained single labeling for D2R (n=152) and α7nAChR (n=561). These results suggest that classic antipsychotic drugs, all of which block the D2R, may facilitate α7nAChR-mediated burst-firing by elimination of D2R-dependent inhibition in neurons expressing both receptors as well as by indirect pre-synaptic and glial mechanisms.
Subject(s)
Dopaminergic Neurons/metabolism , Receptors, Dopamine D2/ultrastructure , Ventral Tegmental Area/metabolism , alpha7 Nicotinic Acetylcholine Receptor/ultrastructure , Animals , Dopaminergic Neurons/ultrastructure , Immunohistochemistry , Male , Mice , Mice, Inbred C57BL , Microscopy, Electron, Transmission , Reward , Ventral Tegmental Area/ultrastructureABSTRACT
Schizophrenia is a severe condition that has been associated with functional abnormalities in dopaminergic (DA) neurons of the ventral tegmental area (VTA). Neurokinin-3 receptors (NK3Rs) of the tachykinin family of neuropeptides modulate the activity of VTA DA neurons and might be involved in DA abnormalities relevant to schizophrenia. Recent work from our lab showed that systemic injection of the dopamine D1/D2 receptor agonist apomorphine in rats, which mimics schizophrenia-like behaviors in humans, also evoked a redistribution of NK3Rs in DA neurons of the rat VTA. In the present study, VTA microinjection of the selective NK3R antagonist SB222200 (1 nmol/0.2 µl) or the nuclear import blocker SN50 (2 µg/0.2 µl) was performed in awake rats 10 min prior to systemic injection of apomorphine. VTA sections were dual immunolabeled for the NK3R (immunogold) and the dopamine synthesizing enzyme tyrosine hydroxylase (TH, immunoperoxidase). Electron microscopic quantifications of somatic and dendritic densities of NK3 immunogold particles were compared in rats receiving central and systemic injections. In DA (TH-labeled) dendrites, VTA microinjection of SB222200 prevented the apomorphine-evoked decrease in surface NK3R density as well as the apomorphine-induced increase in cytoplasmic NK3R density. In contrast, VTA microinjection of SN50, but not SB222200, prevented the apomorphine-induced increase in nuclear NK3R density. VTA microinjection of SB222200 or SN50 without apomorphine had no effect on the NK3R distribution or density in TH and non-TH profiles within the VTA. In non-TH, presumably GABAergic neurons of the VTA, the NK3R densities in somata and dendrites were not significantly changed by apomorphine with or without SB222200. The results suggest that the NK3R antagonist SB222200 is effective against the apomorphine-evoked NK3R internalization in VTA DA dendrites, but does not prevent nuclear NK3R trafficking in VTA DA neurons. These results might have important implications in targeting NK3R antagonists in basic or clinical studies.
Subject(s)
Apomorphine/administration & dosage , Cell Nucleus/drug effects , Dopaminergic Neurons/drug effects , Quinolines/administration & dosage , Receptors, Neurokinin-3/antagonists & inhibitors , Ventral Tegmental Area/drug effects , Animals , Cell Membrane/drug effects , Cell Membrane/ultrastructure , Cell Nucleus/ultrastructure , Dopaminergic Neurons/ultrastructure , Male , Microinjections , Rats , Rats, Sprague-Dawley , Receptors, Neurokinin-3/ultrastructure , Ventral Tegmental Area/ultrastructureABSTRACT
Homeostasis describes the fundamental biological ability of individuals to maintain stable internal conditions in a changing environment. Homeostatic reactions include internal adjustments as well as behavioral responses. In vertebrates, behavioral responses are induced by the reward system. This system originates in the ventral tegmental area (VTA) and leads to increased dopamine levels in the forebrain whenever activated. A major inhibitor of VTA activity is the lateral habenula (LHb). This epithalamic structure is able to almost completely suppress dopamine release, either directly or via the rostromedial tegmental nucleus (RMTg), when rewarding expectations are not met. A major input to the LHb arises from the lateral hypothalamic area (LHA), an important regulator of the homeostatic system. Currently, little is known about the effects of the strong hypothalamic projection on the activity of LHb neurons. In the present study, we analyze neurotransmitters and cellular targets of the LHA-LHb projection in the rat. Therefore, anterograde tracing from the LHA was combined with the visualization of neurotransmitters in the LHb. These experiments revealed a mainly glutamatergic projection, probably exerting excitatory effects on the targeted LHb cells. These cellular targets were analyzed in a second step. Anterograde tracing from the LHA in combination with retrograde tracing from the VTA/RMTg region revealed that LHb neurons projecting to the VTA/RMTg region are densely targeted by the LHA projection. Visualization of synaptophysin at these contact sites indicates that the contact sites indeed are synapses. Taken together, the present study describes a strong mainly glutamatergic projection from the LHA that targets VTA/RMTg-projecting neurons in the LHb. These findings emphasize the potential role of the LHb as direct link between homeostatic areas and reward circuitries, which may be important for the control of homeostatic behaviors.
Subject(s)
Glutamic Acid/metabolism , Habenula/cytology , Hypothalamic Area, Lateral/cytology , Ventral Tegmental Area/cytology , Animals , Habenula/ultrastructure , Hypothalamic Area, Lateral/metabolism , Hypothalamic Area, Lateral/ultrastructure , Male , Neural Pathways/anatomy & histology , Neural Pathways/ultrastructure , Neurons/metabolism , Neurons/ultrastructure , Rats , Rats, Wistar , Ventral Tegmental Area/ultrastructureABSTRACT
The periaqueductal gray (PAG) is a critical brain region involved in opioid analgesia and provides efferents to descending pathways that modulate nociception. In addition, the PAG contains ascending pathways to regions involved in the regulation of reward, including the substantia nigra (SN) and the ventral tegmental area (VTA). SN and VTA contain dopaminergic neurons that are critical for the maintenance of positive reinforcement. Interestingly, the PAG is also reported to contain a population of dopaminergic neurons. In this study, the distribution of catecholaminergic neurons within the ventrolateral (vl) PAG was examined using immunocytochemical methods. In addition, the catecholaminergic PAG neurons were examined to determine whether these neurons are integrated into ascending (VTA, SN) and descending rostral ventral medulla (RVM) efferent pathways from this region. The immunocytochemical analysis determined that catecholaminergic neurons in the PAG are both dopaminergic and noradrenergic and these neurons have a distinct rostrocaudal distribution within the ventrolateral column of PAG. Dopaminergic neurons were concentrated rostrally and were significantly smaller than noradrenergic neurons. Combined immunocytochemistry and tract tracing methods revealed that catecholaminergic neurons are distinct from, but closely associated with, both ascending and descending efferent projection neurons. Finally, by electron microscopy, catecholaminergic neurons showed close dendritic appositions with other neurons in PAG, suggesting a possible nonsynaptic mechanism for regulation of PAG output by these neurons. In conclusion, our data indicate that there are two populations of catecholaminergic neurons in the vlPAG that form dendritic associations with both ascending and descending efferents suggesting a possible nonsynaptic modulation of vlPAG neurons.
Subject(s)
Catecholamines/metabolism , Efferent Pathways/metabolism , Neurons/metabolism , Periaqueductal Gray/metabolism , Animals , Efferent Pathways/ultrastructure , Male , Medulla Oblongata/metabolism , Medulla Oblongata/ultrastructure , Neurons/ultrastructure , Periaqueductal Gray/ultrastructure , Rats , Rats, Sprague-Dawley , Ventral Tegmental Area/metabolism , Ventral Tegmental Area/ultrastructureABSTRACT
The tail of the ventral tegmental area (tVTA), also named the rostromedial tegmental nucleus (RMTg), is a recently defined midbrain structure considered to exert a major inhibitory drive on dopamine systems. In view of its connectivity, tVTA is well placed to convey salient positive and negative signals to dopamine cells and participate in adaptative behavioral responses. This structure could act as a hub converging and integrating widespread multimodal signals toward dopamine systems. The tVTA participates in prediction error, motor control, and responses to aversive stimuli and drugs of abuse. In light of the crucial role of the tVTA in the opiate control of dopamine activity, a neuroanatomical update of the disinhibition model of morphine action is proposed.
Subject(s)
Dopamine/physiology , Ventral Tegmental Area/physiology , Adaptation, Psychological/physiology , Afferent Pathways/physiology , Animals , Arousal/physiology , Avoidance Learning/physiology , Brain Mapping , Dopaminergic Neurons/physiology , Efferent Pathways/physiology , Emotions/physiology , GABAergic Neurons/physiology , Mesencephalon/physiology , Models, Neurological , Motor Activity/physiology , Opioid-Related Disorders/physiopathology , Prosencephalon/physiology , Proto-Oncogene Proteins c-fos/physiology , Rats , Receptors, Opioid, mu/physiology , Reward , Ventral Tegmental Area/ultrastructureABSTRACT
Drugs of abuse increase the release of dopamine from mesocorticolimbic neurons in the ventral tegmental area. Thus, insights into the cytoarchitecture and the synaptic circuitry affecting the activity of dopaminergic neurons in this area are fundamental for understanding the commonalities produced by mechanistically distinct drugs of abuse. Electron microscopic immunolabeling has provided these insights and also shown the critical relationships between the dopaminergic axon terminals and their targeted neurons in the prefrontal cortex and in the both the dorsal and ventral striatum. These brain regions are among those where dopamine and associated neurotransmitters are most implicated in the transition from recreational to compulsive consumption of reinforcing drugs. Thus, the synaptic circuitry and drug-induced plasticity occurring in the ventral tegmental area and in dopamine-targeted regions are reviewed, as both are essential for understanding the long-lasting changes produced by addictive substances.
Subject(s)
Limbic System/physiopathology , Mesencephalon/physiopathology , Neurons/drug effects , Prefrontal Cortex/physiopathology , Substance-Related Disorders/physiopathology , Animals , Dopaminergic Neurons/drug effects , Dopaminergic Neurons/metabolism , Dopaminergic Neurons/ultrastructure , Humans , Limbic System/drug effects , Limbic System/metabolism , Limbic System/ultrastructure , Mesencephalon/drug effects , Mesencephalon/metabolism , Mesencephalon/ultrastructure , Neuronal Plasticity/drug effects , Neurons/metabolism , Neurons/ultrastructure , Nucleus Accumbens/drug effects , Nucleus Accumbens/metabolism , Nucleus Accumbens/physiopathology , Nucleus Accumbens/ultrastructure , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Prefrontal Cortex/ultrastructure , Substance-Related Disorders/metabolism , Substance-Related Disorders/pathology , Ventral Tegmental Area/drug effects , Ventral Tegmental Area/metabolism , Ventral Tegmental Area/physiopathology , Ventral Tegmental Area/ultrastructureABSTRACT
Cocaine-induced plasticity of mesocorticolimbic dopamine (DA) neurons, originating in the ventral tegmental area (VTA), persists in the absence of cocaine and may contribute to both drug-craving and relapse. Glutamate AMPA receptors (AMPARs) in these neurons are implicated in this plasticity. However, there is no ultrastructural evidence that the absence of cocaine following repeated administrations affects the critical surface/synaptic availability of AMPAR GluR1 subunits in either DA or non-DA, putative GABAergic neurons within the VTA. To assess this, we used electron microscopic immunolabeling in the VTA of adult male mice sacrificed at 30 min or 72 h after receiving the final of six (15 mg/kg) cocaine injections, a dosing paradigm that resulted in development of locomotor sensitization. At each time point, both cocaine- and saline-injected mice showed AMPAR GluR1 immunogold labeling in somatodendritic profiles, many of which contained immunoperoxidase labeling for the DA-synthesizing enzyme, tyrosine hydroxylase (TH). At 30 min after the last injection, when cocaine was systemically present, only the non-TH labeled dendrites showed a significant increase in the synaptic/plasmalemmal density of GluR1 immunogold particles. At 72 h, when systemic cocaine was depleted, synaptic GluR1 labeling was greatly enhanced in TH-containing dendrites throughout the VTA and in non-TH dendrites of the limbic-associated paranigral VTA. Our results demonstrate that systemic cocaine produces GluR1 trafficking specifically in non-DA neurons of the VTA, which may subsequently contribute to the abstinent-induced enhancement of AMPA receptor synaptic transmission in mesocorticolimbic DA neurons leading to heightened drug seeking behavior.
Subject(s)
Cocaine-Related Disorders/physiopathology , Cocaine/adverse effects , GABAergic Neurons/drug effects , Nerve Tissue Proteins/metabolism , Neuronal Plasticity/drug effects , Receptors, AMPA/metabolism , Ventral Tegmental Area/drug effects , Animals , Cocaine/administration & dosage , Cocaine/analogs & derivatives , Cocaine/blood , Cocaine-Related Disorders/blood , Cocaine-Related Disorders/metabolism , Cocaine-Related Disorders/pathology , Dendrites/drug effects , Dendrites/metabolism , Dendrites/ultrastructure , Dopamine Uptake Inhibitors/administration & dosage , Dopamine Uptake Inhibitors/adverse effects , Dopamine Uptake Inhibitors/blood , Dopaminergic Neurons/drug effects , Dopaminergic Neurons/metabolism , Dopaminergic Neurons/ultrastructure , GABAergic Neurons/metabolism , GABAergic Neurons/ultrastructure , Male , Mice , Mice, Inbred C57BL , Multivesicular Bodies/drug effects , Multivesicular Bodies/metabolism , Multivesicular Bodies/ultrastructure , Protein Subunits/metabolism , Protein Transport/drug effects , Random Allocation , Substance Withdrawal Syndrome/metabolism , Substance Withdrawal Syndrome/pathology , Substance Withdrawal Syndrome/physiopathology , Tyrosine 3-Monooxygenase/metabolism , Ventral Tegmental Area/metabolism , Ventral Tegmental Area/physiopathology , Ventral Tegmental Area/ultrastructureABSTRACT
Synaptic plasticity in the ventral tegmental area (VTA) is modulated by drugs of abuse and stress and is hypothesized to contribute to specific aspects of addiction. Both excitatory and inhibitory synapses on dopamine neurons in the VTA are capable of undergoing long-term changes in synaptic strength. While the strengthening or weakening of excitatory synapses in the VTA has been widely examined, the role of inhibitory synaptic plasticity in brain reward circuitry is less established. Here, we investigated the effects of drugs of abuse, as well as acute stress, on long-term potentiation of GABAergic synapses onto VTA dopamine neurons (LTP(GABA)). Morphine (10 mg/kg i.p.) reduced the ability of inhibitory synapses in midbrain slices to express LTP(GABA) both at 2 and 24 h after drug exposure but not after 5 days. Cocaine (15 mg/kg i.p.) impaired LTP(GABA) 24 h after exposure, but not at 2 h. Nicotine (0.5 mg/kg i.p.) impaired LTP(GABA) 2 h after exposure, but not after 24 h. Furthermore, LTP(GABA) was completely blocked 24 h following brief exposure to a stressful stimulus, a forced swim task. Our data suggest that drugs of abuse and stress trigger a common modification to inhibitory plasticity, synergizing with their collective effect at excitatory synapses. Together, the net effect of addictive substances or stress is expected to increase excitability of VTA dopamine neurons, potentially contributing to the early stages of addiction.
Subject(s)
Illicit Drugs/pharmacology , Long-Term Potentiation , Neurons , Stress, Physiological , Synapses , Ventral Tegmental Area , Analgesics, Opioid/pharmacology , Animals , Cocaine/pharmacology , Dopamine/metabolism , Dopamine Uptake Inhibitors/pharmacology , Long-Term Potentiation/drug effects , Long-Term Potentiation/physiology , Morphine/pharmacology , Neurons/drug effects , Neurons/metabolism , Neurons/ultrastructure , Nicotine/pharmacology , Nicotinic Agonists/pharmacology , Patch-Clamp Techniques , Rats , Rats, Sprague-Dawley , Receptors, Glucocorticoid/metabolism , Synapses/drug effects , Synapses/physiology , Ventral Tegmental Area/physiology , Ventral Tegmental Area/ultrastructure , gamma-Aminobutyric Acid/metabolismABSTRACT
The concept of cortical-subcortical loops emphasizes the importance of the basal ganglia for motor, psychomotor, and emotional cortical functions. These loops are bidirectionally controlled by the midbrain dopaminergic system, predominantly but not exclusively at the level of the striatum including the accumbens nucleus. Successful behaviors increase the activities of the mesostriatal (arising in the complex part of the substantia nigra) and mesolimbic (arising in the ventral tegmental area, VTA) neurons, thereby reinforcing the corresponding actions. In contrast, unsuccessful behaviors result in an increased activation of the lateral habenular complex (LHb), thereby decreasing the activities of mesolimbic neurons. Correspondingly, electrical stimulation of the LHb effectively blocks neuronal activity in the VTA. Whether this block is due to an inhibitory projection from the LHb to the VTA, or whether axons from excitatory LHb neurons target inhibitory neurons within the VTA, is presently not known. Here we show, using in situ hybridization and immunocytochemical double labeling at the light and electron microscopic level, that GABAergic neurons are scarce in the LHb and that glutamatergic axons from the LHb mostly target GABAergic neurons in the VTA and the mesopontine rostromedial tegmental nucleus (RMTg), also known as tail of the VTA (tVTA). These data explain the inhibitory effect of LHb activation on the VTA. In addition, however, a small number of LHb terminals in the VTA actually contacts dopaminergic neurons. The biological importance of these terminals requires further investigation.
Subject(s)
Axons/metabolism , Glutamic Acid/metabolism , Habenula/ultrastructure , Mesencephalon/metabolism , Neurons/metabolism , gamma-Aminobutyric Acid/metabolism , Animals , Dopamine/metabolism , Female , Habenula/metabolism , Male , Mesencephalon/ultrastructure , Neurons/ultrastructure , Presynaptic Terminals/metabolism , Presynaptic Terminals/ultrastructure , Rats , Rats, Wistar , Synaptic Vesicles/metabolism , Ventral Tegmental Area/metabolism , Ventral Tegmental Area/ultrastructure , Vesicular Glutamate Transport Protein 2/metabolismABSTRACT
The high-affinity choline transporter (CHT) is a protein integral to the function of cholinergic neurons in the central nervous system (CNS). We examined the ultrastructural distribution of CHT in axonal arborizations of the mesopontine tegmental cholinergic neurons, a cell group in which CHT expression has yet to be characterized at the electron microscopic level. By using silver-enhanced immunogold detection, we compared the morphological characteristics of CHT-immunoreactive axon varicosities specifically within the anteroventral thalamus (AVN) and the ventral tegmental area (VTA). We found that CHT-immunoreactive axon varicosities in the AVN displayed a smaller cross-sectional area and a lower frequency of synapse formation and dense-cored vesicle content than CHT-labeled profiles in the VTA. We further examined the subcellular distribution of CHT and observed that immunoreactivity for this protein was predominantly localized to synaptic vesicles and minimally to the plasma membrane of axons in both regions. This pattern is consistent with the subcellular distribution of CHT displayed in other cholinergic systems. Axons in the AVN showed significantly higher levels of CHT immunoreactivity than those in the VTA and correspondingly displayed a higher level of membrane CHT labeling. These novel findings have important implications for elucidating regional differences in cholinergic signaling within the thalamic and brainstem targets of the mesopontine cholinergic system.
Subject(s)
Axons/ultrastructure , Membrane Transport Proteins/metabolism , Thalamus/metabolism , Ventral Tegmental Area/metabolism , Animals , Axons/metabolism , Immunoenzyme Techniques , Immunohistochemistry , Male , Membrane Transport Proteins/genetics , Rats , Rats, Sprague-Dawley , Thalamus/ultrastructure , Ventral Tegmental Area/ultrastructureABSTRACT
The ventral tegmental area (VTA) contributes to reward and motivation signaling. In addition to the well established populations of dopamine (DA) or GABA VTA neurons, glutamatergic neurons were recently discovered in the VTA. These glutamatergic neurons express the vesicular glutamate transporter 2, VGluT2. To investigate whether VTA glutamatergic neurons establish local synapses, we tagged axon terminals from resident VTA neurons by intra-VTA injection of Phaseolus vulgaris leucoagglutinin (PHA-L) or an adeno-associated virus encoding wheat germ agglutinin (WGA) and by immunoelectron microscopy determined the presence of VGluT2 in PHA-L- or WGA-positive terminals. We found that PHA-L- or WGA-positive terminals from tagged VTA cells made asymmetric or symmetric synapses within the VTA. VGluT2 immunoreactivity was detected in the vast majority of PHA-L- or WGA-positive terminals forming asymmetric synapses. These results indicate that both VTA glutamatergic and nonglutamatergic (likely GABAergic) neurons establish local synapses. To examine the possible DAergic nature of postsynaptic targets of VTA glutamatergic neurons, we did triple immunolabeling with antibodies against VGluT2, tyrosine hydroxylase (TH), and PHA-L. From triple-labeled tissue, we found that double-labeled PHA-L (+)/VGluT2 (+) axon terminals formed synaptic contacts on dendrites of both TH-positive and TH-negative cells. Consistent with these anatomical observations, in whole-cell slice recordings of VTA neurons we observed that blocking action potential activity significantly decreased the frequency of synaptic glutamatergic events in DAergic and non-DAergic neurons. These observations indicate that resident VTA glutamatergic neurons are likely to affect both DAergic and non-DAergic neurotransmission arising from the VTA.
Subject(s)
Dopamine/physiology , Glutamic Acid/physiology , Neurons/physiology , Synapses/physiology , Ventral Tegmental Area/physiology , Animals , Male , Neurons/ultrastructure , Presynaptic Terminals/physiology , Presynaptic Terminals/ultrastructure , Rats , Rats, Sprague-Dawley , Synapses/ultrastructure , Ventral Tegmental Area/ultrastructureABSTRACT
The midbrain central gray (periaqueductal gray; PAG) mediates defensive behaviors and is implicated in the rewarding effects of opiate drugs. Projections from the PAG to the ventral tegmental area (VTA) suggest that this region might also regulate behaviors involving motivation and cognition. However, studies have not yet examined the morphological features of PAG axons in the VTA or whether they synapse onto dopamine (DA) or GABA neurons. In this study, we injected anterograde tracers into the rat PAG and used immunoperoxidase to visualize the projections to the VTA. Immunogold-silver labeling for tyrosine hydroxylase (TH) or GABA was then used to identify the phenotype of innervated cells. Electron microscopic examination of the VTA revealed axons labeled anterogradely from the PAG, including myelinated and unmyelinated fibers and axon varicosities, some of which formed identifiable synapses. Approximately 55% of these synaptic contacts were of the symmetric (presumably inhibitory) type; the rest were asymmetric (presumably excitatory). These findings are consistent with the presence of both GABA and glutamate projection neurons in the PAG. Some PAG axons contained dense-cored vesicles indicating the presence of neuropeptides in addition to classical neurotransmitters. PAG projections synapsed onto both DA and GABA cells with no obvious selectivity, providing the first anatomical evidence for these direct connections. The results suggest a diverse nature of PAG physiological actions on midbrain neurons. Moreover, as both the VTA and PAG are implicated in the reinforcing actions of opiates, our findings provide a potential substrate for some of the rewarding effects of these drugs.